Skip to search.
 TSX Up 0.40% TSX Ventures Down 0.19%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
129.54 Up 2.43(1.91%) May 27, 4:00PM EDT
Add to Portfolio
Prev Close:127.11
Open:128.12
Bid:126.90 x 200
Ask:131.68 x 100
1y Target Est:131.11
Beta:1.05
Earnings Date:Jul 28 - Aug 3 (Est.)
Day's Range:127.02 - 131.54
52wk Range:55.36 - 133.54
Volume:1,718,399
Avg Vol (3m):1,561,530
Market Cap:20.77B
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 1.91%20.77B
FOLDUp 2.13%1.15B
SHPGUp 0.76%50.68B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.15
Quarterly EPS Est (Jun-15) :-0.53
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-2.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback